|
Part I Overview and Special Population |
|
|
|
1 Infections in Patients with Cancer: Overview |
|
|
3 | (14) |
|
|
|
|
|
|
|
2 Infections in Hematopoietic Stem Cell Transplant Recipients |
|
|
17 | (10) |
|
|
|
|
|
3 Infections in Patients with Hematologic Malignancies |
|
|
27 | (12) |
|
|
|
|
|
4 Infections in Solid Tumor Patients |
|
|
39 | (8) |
|
|
|
5 Infections in Patients with Hematologic Malignancies Treated with Monoclonal Antineoplastic Therapy |
|
|
47 | (20) |
|
|
|
|
|
6 Postsurgery Infections in Cancer Patients |
|
|
67 | (20) |
|
|
|
|
|
Juan Carlos Lopez-Gutierrez |
|
|
|
|
7 Management of Infections in Critically Ill Cancer Patients |
|
|
87 | (8) |
|
|
|
Part II Clinical Syndromes |
|
|
|
8 Management of the Neutropenic Patient with Fever |
|
|
95 | (10) |
|
|
|
|
|
9 Controversies in Empiric Therapy of Febrile Neutropenia |
|
|
105 | (8) |
|
|
|
10 Catheter-Related Infections in Cancer Patients |
|
|
113 | (10) |
|
|
|
|
|
|
|
11 Intravascular Device-Related Infections: Catheter Salvage Strategies and Prevention of Device-Related Infection |
|
|
123 | (20) |
|
|
|
|
|
12 Pneumonia in the Cancer Patient |
|
|
143 | (10) |
|
|
|
|
|
13 Noninfectious Lung Infiltrates That May Be Confused with Pneumonia in the Cancer Patient |
|
|
153 | (14) |
|
|
|
|
|
|
|
|
|
|
|
14 Mucosal Barrier Injury and Infections |
|
|
167 | (8) |
|
|
|
|
|
15 Bacterial Colonization and Host Immunity |
|
|
175 | (6) |
|
|
|
|
|
|
|
16 Neutropenic Enterocolitis and Clostridium difficile Infections |
|
|
181 | (8) |
|
|
|
|
|
|
|
|
|
17 Management of Reactivation of Hepatitis B and Hepatitis C During Antineoplastic Therapy |
|
|
189 | (6) |
|
|
|
|
|
18 Management of Genitourinary Tract Infections |
|
|
195 | (12) |
|
|
|
|
|
19 Central Nervous System Infections in Cancer Patients |
|
|
207 | (12) |
|
|
|
|
|
20 Endocarditis in Oncology Patients |
|
|
219 | (14) |
|
|
|
|
|
21 Skin Disorders Difficult to Distinguish from Infection |
|
|
233 | (24) |
|
|
|
|
|
|
|
Part III Major Etiologic Agents |
|
|
|
22 Overview of Invasive Fungal Disease in Oncology Patients |
|
|
257 | (4) |
|
|
|
23 Diagnosis of Invasive Fungal Disease |
|
|
261 | (12) |
|
|
|
|
|
24 Invasive Candidiasis in Management of Infections in Cancer Patients |
|
|
273 | (10) |
|
|
|
|
|
|
|
|
|
25 Management of Aspergillosis, Zygomycosis, and Other Clinically Relevant Mold Infections |
|
|
283 | (10) |
|
|
|
Dimitrios P. Kontoyiannis |
|
|
26 Cryptococcal Disease and Endemic Mycosis |
|
|
293 | (8) |
|
|
|
|
|
27 Current Controversies in the Treatment of Fungal Infections |
|
|
301 | (16) |
|
|
|
|
|
|
|
28 Fungal Drug Resistance and Pharmacologic Considerations of Dosing Newer Antifungal Therapies |
|
|
317 | (14) |
|
|
|
|
|
29 Immunotherapy for Difficult-to-Treat Invasive Fungal Diseases |
|
|
331 | (10) |
|
|
|
|
|
|
|
30 Cytomegalovirus in Patients with Cancer |
|
|
341 | (18) |
|
|
|
|
|
|
|
31 Epstein-Barr Virus, Varicella Zoster Virus, and Human Herpes Viruses-6 and -8 |
|
|
359 | (12) |
|
|
|
|
|
|
|
371 | (16) |
|
|
|
|
|
|
|
33 BK, JC, and Parvovirus Infections in Patients with Hematologic Malignancies |
|
|
387 | (10) |
|
|
|
|
|
34 Antiviral Resistance and Implications for Prophylaxis |
|
|
397 | (12) |
|
|
|
35 Management of Gram-Positive Bacterial Disease: Staphylococcus aureus, Streptococcal, Pneumococcal, and Enterococcal Infections |
|
|
409 | (14) |
|
|
|
|
|
36 Infections Caused by Aerobic and Anaerobic Gram-Negative Bacilli |
|
|
423 | (12) |
|
|
|
|
|
|
|
37 Listeriosis and Nocardiosis |
|
|
435 | (8) |
|
|
|
|
|
38 Antibacterial Distribution and Drug--Drug Interactions in Cancer Patients |
|
|
443 | (12) |
|
|
|
|
|
39 Mycobacterium tuberculous Infection |
|
|
455 | (8) |
|
|
|
40 Nontuberculous Mycobacterial Infections |
|
|
463 | (6) |
|
|
|
41 Parasitic Infections in Cancer Patients: Toxoplasmosis, Strongyloidiasis, and Other Parasites |
|
|
469 | (12) |
|
|
|
|
|
42 Zoonoses in Cancer Patients |
|
|
481 | (10) |
|
|
|
Part IV Management of Antimicrobial Therapy |
|
|
|
43 Antimicrobial Stewardship: Considerations for a Cancer Center |
|
|
491 | (8) |
|
|
|
|
|
|
|
44 Controversies in Antimicrobial Stewardship |
|
|
499 | (8) |
|
|
|
45 Prevention of Antimicrobial Resistance: Current and Future Strategies |
|
|
507 | (14) |
|
|
|
|
|
Part V Infection Prevention: Antimicorbial Prophylaxis and Immunization |
|
|
|
46 Antibacterial, Antifungal, and Antiviral Prophylaxis in High-Risk Cancer and Stem Cell Transplant Population |
|
|
521 | (12) |
|
|
|
|
|
47 Controversies in Antimicrobial Prophylaxis |
|
|
533 | (8) |
|
|
|
|
|
48 Infection Prevention -- Protected Environment and Infection Control |
|
|
541 | (10) |
|
|
|
49 Prevention of Tropical and Parasitic Infections: The Immunocompromised Traveler |
|
|
551 | (10) |
|
|
|
|
|
50 Prophylactic Vaccination of Cancer Patients and Hematopoietic Stem Cell Transplant Recipients |
|
|
561 | |
|
|
|
|
| Erratum |
|
1 | (572) |
| Index |
|
573 | |
Daugiau apie elektronines knygas